GB0102673D0 - Compounds - Google Patents

Compounds

Info

Publication number: GB0102673D0
Authority: GB; United Kingdom
Prior art keywords: compounds
Prior art date: 2001-02-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0102673.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-02

Filing date

2001-02-02

Publication date

2001-03-21

2001-02-02 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-02-02 Priority to GBGB0102673.1A priority Critical patent/GB0102673D0/en

2001-03-21 Publication of GB0102673D0 publication Critical patent/GB0102673D0/en

2002-01-31 Priority to EP02710824A priority patent/EP1366047A1/en

2002-01-31 Priority to PCT/EP2002/000991 priority patent/WO2002062793A1/en

2002-01-31 Priority to JP2002563146A priority patent/JP2004521903A/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

GBGB0102673.1A 2001-02-02 2001-02-02 Compounds Ceased GB0102673D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB0102673.1A GB0102673D0 (en)	2001-02-02	2001-02-02	Compounds
EP02710824A EP1366047A1 (en)	2001-02-02	2002-01-31	Thiazole compounds as tgf-beta inhibitors
PCT/EP2002/000991 WO2002062793A1 (en)	2001-02-02	2002-01-31	Thiazole compounds as tgf-beta inhibitors
JP2002563146A JP2004521903A (en)	2001-02-02	2002-01-31	Thiazole compounds as TGF-β inhibitors

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0102673.1A GB0102673D0 (en)	2001-02-02	2001-02-02	Compounds

Publications (1)

Publication Number	Publication Date
GB0102673D0 true GB0102673D0 (en)	2001-03-21

Family

ID=9908019

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0102673.1A Ceased GB0102673D0 (en)	2001-02-02	2001-02-02	Compounds

Country Status (4)

Country	Link
EP (1)	EP1366047A1 (en)
JP (1)	JP2004521903A (en)
GB (1)	GB0102673D0 (en)
WO (1)	WO2002062793A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0123589D0 (en) *	2001-10-01	2001-11-21	Syngenta Participations Ag	Organic compounds
GB0127433D0 (en) *	2001-11-15	2002-01-09	Smithkline Beecham Corp	Compounds
AR039241A1 (en)	2002-04-04	2005-02-16	Biogen Inc	HETEROARILOS TRISUSTITUIDOS AND METHODS FOR ITS PRODUCTION AND USE OF THE SAME
GB0217787D0 (en) *	2002-07-31	2002-09-11	Glaxo Group Ltd	C ompounds
MXPA05002982A (en) *	2002-09-18	2005-06-22	Pfizer Prod Inc	Triazole derivatives as transforming growth factor (tgf) inhibitors.
ES2323421T3 (en)	2002-09-18	2009-07-15	Pfizer Products Inc.	NEW OXAZOL COMPOUNDS AS INHIBITORS OF THE GROWTH FACTOR TRANSFORMER (TGF).
DE102005048072A1 (en) *	2005-09-24	2007-04-05	Bayer Cropscience Ag	Thiazoles as fungicides
ES2538265T3 (en)	2006-10-03	2015-06-18	Genzyme Corporation	Antibodies against TGF-beta for use in the treatment of infants at risk of developing bronchopulmonary dysplasia
UY31281A1 (en) *	2007-08-13	2009-03-31		AMINAS, BENZAMIDS AND SULFONAMIDS {[4- (5,6-DIMETIL-2-PIRIDIN-2-IL-PIRIDIN-3-IL) OXIPIRIDIN-2-IL] AMINO} SUBSTITUTED, ITS PHARMACUTICALLY ACCEPTABLE SALTS, COMPOSITIONS AND APPLIED APPLICATIONS.
US20140308275A1 (en)	2011-07-27	2014-10-16	Inserm (Institut National De La Sante Et De La Recherche Medicale	Methods for diagnosing and treating myhre syndrome
CA2853484C (en)	2011-10-26	2018-08-21	Seattle Children's Research Institute	Cysteamine in the treatment of fibrotic disease
WO2014058317A1 (en)	2012-10-10	2014-04-17	Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis	Methods and means for predicting resistance to anti-cancer treatment
WO2020201362A2 (en)	2019-04-02	2020-10-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods of predicting and preventing cancer in patients having premalignant lesions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5583103A (en) *	1988-06-28	1996-12-10	La Jolla Cancer Research Foundation	Inhibition of transforming growth factor beta activity
DE69228700T2 (en) *	1991-12-04	1999-09-09	La Jolla Cancer Research Foundation	Use of decorin or biglycan in the manufacture of a medicament for the treatment of diabetes-related conditions
DE69434617D1 (en) *	1993-11-19	2006-04-06	Univ Sydney	PROCEDURE FOR PROPHYLAXIS OR CONTROL OF THE CATARACT

2001
- 2001-02-02 GB GBGB0102673.1A patent/GB0102673D0/en not_active Ceased
2002
- 2002-01-31 JP JP2002563146A patent/JP2004521903A/en not_active Withdrawn
- 2002-01-31 WO PCT/EP2002/000991 patent/WO2002062793A1/en not_active Ceased
- 2002-01-31 EP EP02710824A patent/EP1366047A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2002062793A1 (en)	2002-08-15
JP2004521903A (en)	2004-07-22
EP1366047A1 (en)	2003-12-03

Publication	Publication Date	Title
AU2002349297A8 (en)	2003-06-17	Statin-like compounds
GB0124463D0 (en)	2001-12-05	Compounds
GB0101996D0 (en)	2001-03-14	Organtic compounds
GB0102668D0 (en)	2001-03-21	Compounds
GB0112324D0 (en)	2001-07-11	Compounds
GB0102665D0 (en)	2001-03-21	Compounds
GB0121488D0 (en)	2001-10-24	Compounds
GB0127433D0 (en)	2002-01-09	Compounds
GB0102673D0 (en)	2001-03-21	Compounds
GB0119474D0 (en)	2001-10-03	Compounds
GB0119472D0 (en)	2001-10-03	Compounds
GB0115178D0 (en)	2001-08-15	Compounds
GB0118364D0 (en)	2001-09-19	Compounds
GB0120344D0 (en)	2001-10-17	Compounds
GB0119473D0 (en)	2001-10-03	Compounds
GB0108097D0 (en)	2001-05-23	Compounds
GB0105098D0 (en)	2001-04-18	Compounds
GB0104397D0 (en)	2001-04-11	Compounds
GB0115863D0 (en)	2001-08-22	Compounds
GB0106673D0 (en)	2001-05-09	Compounds
GB0105737D0 (en)	2001-04-25	Compounds
GB0111183D0 (en)	2001-06-27	Compounds
GB0104401D0 (en)	2001-04-11	Compounds
GB0104399D0 (en)	2001-04-11	Compounds
GB0111184D0 (en)	2001-06-27	Compounds

Legal Events

Date	Code	Title	Description
2002-05-01	AT	Applications terminated before publication under section 16(1)